Hematology NewsConcern over response to COVID-19 in patients with blood cancersJanuary 12, 2021COVID-19 UpdatesB Cell Lymphoma
Hematology NewsFour-item prognostic index predicts survival in adult Burkitt lymphomaDecember 16, 2020B Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsSynthetic lethality: Triple combination is a viable strategy for B-cell malignanciesDecember 11, 2020B Cell LymphomaDLBCLLymphoma & Plasma Cell DisordersCLL
Hematology NewsZUMA-12 study shows frontline axi-cel has substantial activity in high-risk large B-cell lymphomaDecember 11, 2020B Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsPediatric regimens better for adolescents/young adults with aggressive B-cell NHLDecember 10, 2020B Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsBispecific antibody odronextamab demonstrates durable complete responses in refractory NHLDecember 10, 2020B Cell LymphomaLymphoma & Plasma Cell DisordersDLBCL
Hematology NewsZUMA-5: Axi-cel yields high response rate in indolent NHLDecember 6, 2020B Cell LymphomaLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology NewsCOVID-19–related outcomes poor for patients with hematologic disease in ASH registryDecember 5, 2020COVID-19 UpdatesALLMultiple MyelomaB Cell LymphomaNon-Hodgkin Lymphoma
Pigment traits, sun sensitivity associated with risk of non-Hodgkin lymphomas and chronic lymphocytic leukemiaNovember 24, 2020CLLB Cell LymphomaT Cell LymphomasLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNonmelanoma Skin CancerMixed Topics
Hematology NewsCAR T for all R/R DLBCL patients: The jury is still outOctober 28, 2020B Cell LymphomaDLBCL
Hematology NewsOlder age, r/r disease in lymphoma patients tied to increased COVID-19 death rateOctober 20, 2020B Cell LymphomaCOVID-19 UpdatesLymphoma & Plasma Cell Disorders
Hematology NewsEfforts to close the ‘AYA gap’ in lymphomaOctober 20, 2020Lymphoma & Plasma Cell DisordersB Cell LymphomaHodgkin LymphomaPatient & Survivor Care
Hematology NewsSeven things to know about new lymphoma drug tafasitamabOctober 9, 2020DLBCLB Cell LymphomaLymphoma & Plasma Cell Disorders
Oncology PracticeSurvey quantifies COVID-19’s impact on oncologySeptember 20, 2020COVID-19 UpdatesBreast CancerCNS/Brain CancerDLBCLFollicular LymphomaLung CancerLeukemia, Myelodysplasia, Transplantation
Hematology NewsNapabucasin suppressed tumor growth in DLBCL cell linesSeptember 2, 2020B Cell LymphomaLymphoma & Plasma Cell Disorders
